Literature DB >> 20163445

Insulin-like growth factor-1 is associated with cognitive outcome in infantile spasms.

Raili S Riikonen1, Jarmo Jääskeläinen, Ursula Turpeinen.   

Abstract

PURPOSE: The molecular mechanisms that lead to long-term consequences of infantile spasms (IS) are poorly understood. Insulin-like growth factor-1 (IGF-1) is regulated by insults that might be stressful to the brain, and is crucial for early brain development. The aim of the present study was to correlate cerebrospinal fluid (CSF) levels of IGF-1 with antecedent insults and cognitive outcome.
METHODS: We studied CSF IGF-1 and the adrenocorticotropic hormone (ACTH) concentrations in infants with idiopathic IS (IIS), symptomatic IS (SIS), and controls.
RESULTS: Infants with IIS had CSF IGF-1 concentrations similar to those of the control children, but children with SIS had markedly low CSF IGF-1 concentrations. In addition, CSF ACTH concentrations were significantly lower in the children with SIS than in those with IIS. High CSF IGF-1 concentrations were associated with an idiopathic etiology, absence of early (pre- or perinatal) insults or stress, normal brain imaging studies, good response to ACTH therapy, and favorable cognitive outcome. Low CSF IGF-1 concentrations were associated with low CSF ACTH concentrations, a history of early insults or stress, cerebral atrophy, poor response to therapy, and poor cognitive outcome. DISCUSSION: In children with IS, insults or stress in early life may affect the synthesis of IGF-1, which might play a role in the reduction of certain cognitive functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20163445     DOI: 10.1111/j.1528-1167.2009.02499.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  11 in total

1.  Epilepsy: Update to guidelines on treatment of infantile spasms.

Authors:  Raili Riikonen
Journal:  Nat Rev Neurol       Date:  2012-08-07       Impact factor: 42.937

Review 2.  Recent advances in the pharmacotherapy of infantile spasms.

Authors:  Raili Riikonen
Journal:  CNS Drugs       Date:  2014-04       Impact factor: 5.749

3.  A Role for Insulin-like Growth Factor 1 in the Generation of Epileptic Spasms in a murine model.

Authors:  Carlos J Ballester-Rosado; John T Le; Trang T Lam; Carrie A Mohila; Sandi Lam; Anne E Anderson; James D Frost; John W Swann
Journal:  Ann Neurol       Date:  2022-05-10       Impact factor: 11.274

Review 4.  Prenatal corticosteroids modify glutamatergic and GABAergic synapse genomic fabric: insights from a novel animal model of infantile spasms.

Authors:  D A Iacobas; S Iacobas; T Chachua; C Goletiani; G Sidyelyeva; J Velíšková; L Velíšek
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

Review 5.  WONOEP appraisal: Molecular and cellular biomarkers for epilepsy.

Authors:  Lauren E Walker; Damir Janigro; Uwe Heinemann; Raili Riikonen; Christophe Bernard; Manisha Patel
Journal:  Epilepsia       Date:  2016-07-04       Impact factor: 5.864

Review 6.  Estrogen-IGF-1 interactions in neuroprotection: ischemic stroke as a case study.

Authors:  Farida Sohrabji
Journal:  Front Neuroendocrinol       Date:  2014-05-29       Impact factor: 8.606

7.  Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome.

Authors:  Omar S Khwaja; Eugenia Ho; Katherine V Barnes; Heather M O'Leary; Luis M Pereira; Yaron Finkelstein; Charles A Nelson; Vanessa Vogel-Farley; Geneva DeGregorio; Ingrid A Holm; Umakanth Khatwa; Kush Kapur; Mark E Alexander; Deirdre M Finnegan; Nicole G Cantwell; Alexandra C Walco; Leonard Rappaport; Matt Gregas; Raina N Fichorova; Michael W Shannon; Mriganka Sur; Walter E Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-12       Impact factor: 11.205

8.  The Association between IGF-1 Polymorphisms, IGF-1 Serum Levels, and Cognitive Functions in Healthy Adults: The Amsterdam Growth and Health Longitudinal Study.

Authors:  Carmilla M M Licht; Lise C van Turenhout; Jan Berend Deijen; Lando L J Koppes; Willem van Mechelen; Jos W R Twisk; Madeleine L Drent
Journal:  Int J Endocrinol       Date:  2014-07-10       Impact factor: 3.257

9.  Serum insulin-like growth factor 1 (IGF-1) in multiple sclerosis: relation to cognitive impairment and fatigue.

Authors:  Rania S Nageeb; Noha A Hashim; Amal Fawzy
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2018-09-15

10.  MAOA Influences the Trajectory of Attentional Development.

Authors:  Rebecca A Lundwall; Claudia G Rasmussen
Journal:  Front Hum Neurosci       Date:  2016-08-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.